Care Twentyone Corporation (JP:2373)
:2373
Japanese Market
Advertisement

Care Twentyone Corporation (2373) AI Stock Analysis

Compare
0 Followers

Top Page

JP:2373

Care Twentyone Corporation

(2373)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - 4o)
Rating:58Neutral
Price Target:
¥479.00
▲(4.36% Upside)
The overall stock score of 58 reflects moderate financial performance with steady revenue growth but challenges in profitability and cash flow management. Technical analysis indicates mixed signals with short-term bearish momentum but potential for a rebound. The stock's valuation is attractive due to a low P/E ratio and a solid dividend yield, which provides a cushion for investors.

Care Twentyone Corporation (2373) vs. iShares MSCI Japan ETF (EWJ)

Care Twentyone Corporation Business Overview & Revenue Model

Company DescriptionCare Twentyone Corporation provides nursing care services in Japan. The company offers home-visit care, paid nursing home, dementia group home, home care support, small-scale multi-functional home care, day service, childcare services, and rents welfare equipment, as well as home renovation business. It operates support projects for people with disabilities; visiting nursing, medical support, and acupuncture visiting massage business; and nursing care qualification acquisition, human resources introduction/dispatch, and life support business. In addition, the company develops land for real estate owners; operates dining facilities and meal delivery services; and employment support for people with disabilities. The company was incorporated in 1993 and is headquartered in Osaka, Japan.
How the Company Makes MoneyCare Twentyone Corporation generates revenue through multiple streams, primarily from its residential care facilities and home healthcare services. The company charges clients for accommodations, medical care, and support services, which can be billed on a monthly or per-service basis. Additionally, Care Twentyone may partner with insurance providers and government programs to facilitate coverage for their services, enhancing accessibility for clients. Significant partnerships with healthcare networks and local agencies also contribute to their earnings by providing referrals and expanding their service reach. Furthermore, the company may engage in wellness programs and rehabilitation services that are billed separately, adding to its overall revenue.

Care Twentyone Corporation Financial Statement Overview

Summary
Care Twentyone Corporation exhibits moderate financial health with steady revenue growth but faces challenges in profitability and cash flow management. High leverage remains a concern, potentially impacting future financial flexibility. The company needs to focus on improving operational efficiency and cash generation to enhance financial stability and shareholder value.
Income Statement
55
Neutral
The income statement shows a modest revenue growth of 10.45% in the latest year, indicating a steady growth trajectory. However, the company is struggling with profitability, as evidenced by a negative EBIT and declining net income. Gross profit margin remains stable, but net profit margin is low due to high operational costs, impacting overall profitability. The negative EBIT margin suggests operational inefficiencies.
Balance Sheet
60
Neutral
The balance sheet reveals a high debt-to-equity ratio, indicating significant leverage which poses financial risk. Although the equity ratio is relatively low, the company maintains a reasonable return on equity (ROE), suggesting that it uses its equity efficiently despite the high debt level. The company's high liabilities relative to its equity may constrain its financial flexibility.
Cash Flow
50
Neutral
Cash flow analysis shows volatility with a significant decline in free cash flow in the latest year. The free cash flow to net income ratio is concerning, highlighting potential liquidity issues. Operating cash flow is positive but has decreased significantly, indicating challenges in converting revenue into cash. This trend may affect the company's ability to fund operations and growth without relying on external financing.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue47.06B45.40B41.10B38.40B36.36B33.98B
Gross Profit10.35B9.66B9.01B9.27B8.73B7.67B
EBITDA2.21B2.20B2.33B3.12B3.53B3.11B
Net Income714.39M278.42M6.16M630.49M937.08M704.64M
Balance Sheet
Total Assets31.23B31.67B31.82B36.38B37.60B36.20B
Cash, Cash Equivalents and Short-Term Investments3.61B3.08B2.61B1.88B2.83B2.94B
Total Debt20.29B19.49B18.34B22.51B22.96B24.07B
Total Liabilities27.15B26.94B26.30B29.90B30.83B31.12B
Stockholders Equity4.04B4.71B5.50B6.46B6.77B5.07B
Cash Flow
Free Cash Flow0.00-502.44M479.68M184.12M1.42B2.14B
Operating Cash Flow0.00709.85M2.14B1.11B2.61B2.88B
Investing Cash Flow0.00-1.02B-2.60B-1.39B-1.38B-1.11B
Financing Cash Flow0.00782.01M1.20B-679.93M-1.33B-77.19M

Care Twentyone Corporation Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price459.00
Price Trends
50DMA
467.15
Negative
100DMA
437.73
Positive
200DMA
407.42
Positive
Market Momentum
MACD
-7.89
Positive
RSI
43.96
Neutral
STOCH
38.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2373, the sentiment is Neutral. The current price of 459 is below the 20-day moving average (MA) of 494.61, below the 50-day MA of 467.15, and above the 200-day MA of 407.42, indicating a neutral trend. The MACD of -7.89 indicates Positive momentum. The RSI at 43.96 is Neutral, neither overbought nor oversold. The STOCH value of 38.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:2373.

Care Twentyone Corporation Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
¥3.03B11.542.53%-3.06%-38.56%
75
Outperform
¥4.44B10.8415.78%120.80%
72
Outperform
¥2.54B5.404.52%2.45%205.19%
68
Neutral
¥3.14B9.352.67%4.69%103.59%
58
Neutral
¥6.20B10.293.70%7.60%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
44
Neutral
¥17.19B-8.9310.09%-340.83%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:2373
Care Twentyone Corporation
459.00
78.36
20.59%
JP:2425
Care Service Co., Ltd.
798.00
-25.84
-3.14%
JP:2435
Cedar. Co.,Ltd
221.00
2.01
0.92%
JP:7091
Living Platform Ltd.
992.00
30.00
3.12%
JP:7129
Miahelsa Holdings Corporation
1,123.00
84.11
8.10%
JP:9229
SUNWELS Co.,Ltd.
512.00
-255.04
-33.25%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 05, 2025